Stacey L. Porter Form 3 Outset Medical / Stacey L. Porter ownership change

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0104
Estimated average burden
hours per response:	0.5

1. Name and Address of Reporting Person^*

Porter Stacey L.

(Last) (First) (Middle)

3052 ORCHARD DRIVE

(Street)

SAN JOSE CA 95134

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
10/15/2021

3. Issuer Name and Ticker or Trading Symbol
Outset Medical, Inc. [ OM ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
Chief People Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	11,784	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (right to buy)	(1)	12/12/2028	Common Stock	31,139	4.11	D
Non-Qualified Stock Option (right to buy)	(2)	09/10/2029	Common Stock	7,898	6.25	D
Non-Qualified Stock Option (right to buy)	(2)	02/03/2030	Common Stock	1,898	8.62	D
Non-Qualified Stock Option (right to buy)	(3)	03/08/2031	Common Stock	10,296	46.94	D
Performance Options (right to buy)	(4)	12/12/2028	Common Stock	20,759	4.11	D
Performance Options (right to buy)	(4)	09/10/2029	Common Stock	5,265	6.25	D
Performance Options (right to buy)	(4)	02/03/2030	Common Stock	1,265	8.62	D

Explanation of Responses:

1. This option vests in 48 equal monthly installments beginning on December 12, 2018, subject to the reporting person's continued employment through the applicable vesting date.

2. This option vests in 48 equal monthly installments, subject to the reporting person's continuous service through the applicable vesting date.

3. This option vests 25% on March 8, 2022 and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date.

4. All shares subject to this grant fully vested on March 15, 2021, after meeting performance criteria.

	By: John L. Brottem For: Stacey L. Porter	10/21/2021
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.